Founder Dr. Matt Leavitt Assumes Executive Chairman Post
Advanced Dermatology and Cosmetic Surgery (ADCS), a national leader in dermatology care, today announced that Brian T. Griffin has been appointed as Chief Executive Officer.
Dr. Matt Leavitt, who had been serving as CEO, has stepped into the role of Executive Chairman, replacing Daniel D. Crowley. Dr. Leavitt will continue to be actively engaged with the firm’s physician executive leaders and executing on the company’s mission of delivering clinical excellence.
"I am thrilled to welcome Brian as our new CEO. He brings the right experience and skills to lead ADCS to the next level," said Dr. Leavitt, Founder of ADCS. "ADCS is the clear leader in dermatology practice management. It has emerged from the challenges posed by COVID-19 on a strong footing and is a stable platform on which to build, and Brian is the right leader to help our team create the most of this opportunity."
Dr. Leavitt added, "We thank Mr. Crowley for his service and wish him well. He was instrumental in helping our young and growing firm implement management practices and systems infrastructure to support future growth."
Mr. Griffin was most recently Chairman and CEO of Diplomat Pharmacy Inc. (NYSE: DPLO), which was the largest independent provider of specialty pharmacy services in the United States. The company was acquired by Optum Rx, a subsidiary of UnitedHealth Group (NYSE: UNH) in February 2020. As an independent company, Diplomat partnered with manufacturers, payers, providers, hospitals and more. Based in Flint, Michigan, Diplomat had facilities across the United States and dispensed drugs in all 50 states.
Prior to his role at Diplomat, Mr. Griffin was with Anthem Inc. (NYSE: ANTM), where he was Executive Vice President and President of the Commercial and Specialty Business Division and was responsible for Anthem’s 14 Blue Cross and Blue Shield Plans nationally. In addition, he had responsibility for Anthems’s enterprise-wide pharmacy business as President of Anthem Pharmacy Solutions and, ultimately, as CEO of IngenioRx, Anthem’s newly launched PBM. Mr. Griffin also held leadership positions at Express Scripts (NYSE: ESI) and Medco Health Solutions (NYSE: MHS), where, as CEO of Medco International, he led its businesses outside the U.S. Before that, he was President of Medco’s Health Plans Division and Senior Vice President and Chief Sales Officer of Merck-Medco Managed Care Inc. Mr. Griffin serves on the Board of Trustees of Visiting Nurse Association Health Group (VNAHG), where he was Chairman for four years. VNAHG provides home nursing and physician services in New Jersey and Ohio.
"As an organization dedicated to high-quality care and patient service, and distinguished by strong physician leadership and engagement, ADCS is exceptionally well positioned for a leadership role in dermatology in the months and years ahead," said Mr. Griffin. "I look forward to working with Dr. Leavitt, the physician leadership, and the management team to continue building an enduring organization that attracts and supports the nation’s best dermatology practitioners."
ABOUT ADVANCED DERMATOLOGY AND COSMETIC SURGERY
Advanced Dermatology and Cosmetic Surgery is the premier dermatology practice in the country. We are committed to providing comprehensive and unparalleled dermatologic and aesthetic care in a welcoming and engaging environment, seeking to make each patient experience unique. We strive to combine the best of the art of medicine with the latest advances in research and technology in formulating individualized treatment plans to achieve the desired result with superior patient safety and privacy standards. To learn more about Advanced Dermatology, visit www.advancedderm.com or call 1-866-400-DERM.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005313/en/